High flow nasal cannula is a good treatment option for COVID-19.
作者信息
Geng Shike, Mei Qing, Zhu Chunyan, Yang Tianjun, Yang Yun, Fang Xiaowei, Pan Aijun
机构信息
Department of Intensive Care Unit, The Affiliated Provincial Hospital of Anhui Medical University, Hefei 23001, China.
Department of Intensive Care Unit, Division of Life Science and Medicine, The First Affiliated Hospital of USTC (Anhui Provincial Hospital), University of Science and Technology of China, No.17, Lu Jiang Road, Hefei 23001, China.
出版信息
Heart Lung. 2020 Sep-Oct;49(5):444-445. doi: 10.1016/j.hrtlng.2020.03.018. Epub 2020 Apr 11.
Abstract
摘要
相似文献
1
High flow nasal cannula is a good treatment option for COVID-19.
Heart Lung. 2020 Sep-Oct;49(5):444-445. doi: 10.1016/j.hrtlng.2020.03.018. Epub 2020 Apr 11.
2
The utility of high-flow nasal cannula oxygen therapy in the management of respiratory failure secondary to COVID-19 pneumonia.
S Afr Med J. 2020 May 7;110(6):12941.
3
High-flow nasal cannula for COVID-19 patients: risk of bio-aerosol dispersion.
Eur Respir J. 2020 Oct 8;56(4). doi: 10.1183/13993003.03136-2020. Print 2020 Oct.
4
High-flow nasal cannula for COVID-19 patients: risk of bio-aerosol dispersion.
Eur Respir J. 2020 Oct 8;56(4). doi: 10.1183/13993003.03004-2020. Print 2020 Oct.
5
Low-flow nasal cannula oxygen and potential nosocomial spread of COVID-19.
Br J Anaesth. 2020 Sep;125(3):e309-e310. doi: 10.1016/j.bja.2020.05.011. Epub 2020 May 18.
6
Monitoring of high-flow nasal cannula for SARS-CoV-2 severe pneumonia: less is more, better look at respiratory rate.
Intensive Care Med. 2020 Nov;46(11):2094-2095. doi: 10.1007/s00134-020-06199-9. Epub 2020 Jul 31.
7
High-flow nasal cannula for COVID-19 patients: low risk of bio-aerosol dispersion.
Eur Respir J. 2020 May 14;55(5). doi: 10.1183/13993003.00892-2020. Print 2020 May.
8
High-flow nasal cannula may be no safer than non-invasive positive pressure ventilation for COVID-19 patients.
Crit Care. 2020 Apr 23;24(1):169. doi: 10.1186/s13054-020-02892-9.
9
[Recommendations for critically ill patients with COVID-19].
Med Klin Intensivmed Notfmed. 2020 Apr;115(3):175-177. doi: 10.1007/s00063-020-00674-3.
10
Improving the Safety of High-Flow Therapies in the Management of Patients With COVID-19.
Chest. 2020 Oct;158(4):1788-1789. doi: 10.1016/j.chest.2020.06.040.
引用本文的文献
1
Characterization and Optimization of the Subsalve Helmet Ventilation Circuit in a High-Fidelity Acute Respiratory Distress Syndrome (ARDS) Lung Model.
Med Devices (Auckl). 2025 Apr 16;18:261-270. doi: 10.2147/MDER.S487868. eCollection 2025.
2
Efficacy of High Flow Nasal Cannula in the Treatment of Patients with COVID-19 with Acute Respiratory Distress Syndrome: Results of Single Centre Study in Vietnam.
Pulm Ther. 2024 Dec;10(4):451-468. doi: 10.1007/s41030-024-00272-0. Epub 2024 Oct 18.
3
[All Roads Lead to Rome: Results of Non-Invasive Respiratory Therapies Applied in a Tertiary-Care Hospital Without an Intermediate Care Unit During the COVID-19 Pandemic].
Open Respir Arch. 2021 Jan 8;3(1):100081. doi: 10.1016/j.opresp.2020.100081. eCollection 2021 Jan-Mar.
4
[COVID-19 Neumonia. What Does Ventilatory Support Offer? Review of a Cohort of Patients Treated in a Second Level Hospital].
Open Respir Arch. 2020 Oct-Dec;2(4):297-298. doi: 10.1016/j.opresp.2020.07.004. Epub 2020 Sep 11.
5
Evaluation and Performance of a Positive Airway Pressure Device (CPAP-AirFlife™): A Randomized Crossover Non-Inferiority Clinical Study in Normal Subjects.
Medicina (Kaunas). 2023 Jul 27;59(8):1372. doi: 10.3390/medicina59081372.
6
Analysis of risk factors for the failure of respiratory support with high-flow nasal cannula oxygen therapy in children with acute respiratory dysfunction: A case-control study.
Front Pediatr. 2022 Aug 23;10:979944. doi: 10.3389/fped.2022.979944. eCollection 2022.
7
Cold Bubble Humidification of Oxygen: Old habits die hard.
Sultan Qaboos Univ Med J. 2022 Aug;22(3):309-313. doi: 10.18295/squmj.1.2022.002. Epub 2022 Aug 25.
8
Predicting the effectiveness of high-flow oxygen therapy in COVID-19 patients: a single-centre observational study.
Anaesthesiol Intensive Ther. 2022;54(1):12-17. doi: 10.5114/ait.2022.113738.
9
Current utilization of interferon alpha for the treatment of coronavirus disease 2019: A comprehensive review.
Cytokine Growth Factor Rev. 2022 Feb;63:34-43. doi: 10.1016/j.cytogfr.2022.01.001. Epub 2022 Jan 13.
10
Noninvasive respiratory support for acute respiratory failure due to COVID-19.
Curr Opin Crit Care. 2022 Feb 1;28(1):25-50. doi: 10.1097/MCC.0000000000000902.
本文引用的文献
1
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.
JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585.
2
An Index Combining Respiratory Rate and Oxygenation to Predict Outcome of Nasal High-Flow Therapy.
Am J Respir Crit Care Med. 2019 Jun 1;199(11):1368-1376. doi: 10.1164/rccm.201803-0589OC.
3
Does high-flow nasal cannula oxygen improve outcome in acute hypoxemic respiratory failure? A systematic review and meta-analysis.
Respir Med. 2017 Oct;131:58-64. doi: 10.1016/j.rmed.2017.08.005. Epub 2017 Aug 9.
4
Comparison of three high flow oxygen therapy delivery devices: a clinical physiological cross-over study.
Minerva Anestesiol. 2013 Dec;79(12):1344-55. Epub 2013 Jul 15.
5
Research in high flow therapy: mechanisms of action.
Respir Med. 2009 Oct;103(10):1400-5. doi: 10.1016/j.rmed.2009.04.007. Epub 2009 May 21.
Zotero 插件